FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to biotechnology, virology and veterinary science. The invention discloses the use of immunogenic compositions containing the PCV2 ORF2 recombinant protein, for inducing an immune response to PCV2 or producing a medicinal agent for inducing an immune response to PCV2. The amount of the PCV2 ORF2 recombinant protein in the composition makes at least 2 mcg. The presented invention can be used in veterinary science.
EFFECT: producing the new composition for veterinary science.
19 cl, 3 dwg, 24 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
PCV2 IMMUNOGENIC COMPOSITIONS AND METHODS OF SUCH COMPOSITIONS PRODUCTION | 2005 |
|
RU2620968C9 |
IMMUNOGENIC COMPOSITIONS PCV2 AND METHODS FOR PRODUCING SUCH COMPOSITIONS | 2005 |
|
RU2435854C2 |
MULTIVALENT IMMUNOGENIC COMPOSITIONS PCV2 AND METHODS FOR PRODUCING THESE COMPOSITIONS | 2006 |
|
RU2577129C2 |
MULTIVALENT IMMUNOGENIC COMPOSITIONS PCV2 AND METHODS FOR PRODUCING THESE COMPOSITIONS | 2006 |
|
RU2577127C9 |
PORCINE CIRCOVIRUS TYPE 3 (PCV3) VACCINES, PRODUCTION AND USE THEREOF | 2020 |
|
RU2813989C2 |
PCV2B DIVERGENT VACCINE COMPOSITION AND METHODS OF USE | 2014 |
|
RU2662685C2 |
TREATING PRDC IN GILTS | 2008 |
|
RU2522849C2 |
RECOMBINANT EXPRESSION OF PROTEIN ORF2 PCV2b IN INSECT CELLS | 2018 |
|
RU2779423C2 |
TREATMENT OF PIGS WITH PCV2 ANTIGEN | 2007 |
|
RU2520087C2 |
POLYVALENT IMMUNOGENIC COMPOSITIONS PCV2 AND METHODS FOR PRODUCING SUCH COMPOSITIONS | 2006 |
|
RU2488407C2 |
Authors
Dates
2016-02-20—Published
2011-05-30—Filed